Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 6/20 | 0.57 |
| ▸ | NMUR1 | Q9HB89 | 6/20 | 0.57 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.53 |
| ▸ | TFPI | P10646 | 4/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30198506 | 0.90 | NMUR2 (0.56) | NMUR2NMUR1EPHA2OPRM1OPRD1 | |
| SCHEMBL30431273 | 0.89 | NMUR2 (0.65) | NMUR2NMUR1TFPINPY1RNPY2R | |
| SCHEMBL30974482 | 0.87 | NMUR2 (0.60) | NMUR2NMUR1EPHA2OPRM1OPRD1 | |
| SCHEMBL31281288 | 0.86 | MAPK8 (0.60) | NMUR2NMUR1EPHA2MAPK8MAPK9 | |
| SCHEMBL31281428 | 0.86 | OPRM1 (0.60) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL31206300 | 0.85 | EPHA2 (0.58) | NMUR2NMUR1EPHA2OPRM1OPRD1 | |
| SCHEMBL29366560 | 0.85 | NMUR2 (0.59) | NMUR2NMUR1OPRM1OPRD1MAPK8 | |
| SCHEMBL29614950 | 0.85 | RAMP3 (0.63) | NMUR2NMUR1EPHA2MAPK8MAPK9 | |
| SCHEMBL29521532 | 0.85 | KDM1A (0.66) | NMUR2NMUR1EPHA2TFPIC5AR1 | |
| SCHEMBL9551316 | 0.85 | EPHA2 (0.59) | EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | claimed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | claimed |
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | disclosed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |
| EP-4484955-A1 | METHOD FOR SCREENING OF EXTRACELLULAR TISSUE PEPTIDES IN MAMMALIAN TISSUE SAMPLES FOR HEALTH STATUS EVALUATION, DISEASE DIAGNOSTICS AND NEOANTIGEN DISCOVERY | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |